IL6 and Alzheimer disease: Serum IgE levels in the mice decreased upon 3′-SL administration (Fig. 3b,d) Furthermore, Plasma IL-1β, IL-6, and TNF-α levels were decreased in 3′-SL-treated mice with AD (Fig. 3a,c).